HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.990
-0.070 (-2.29%)
Oct 29, 2024, 4:00 PM EDT - Market closed

HeartSciences Income Statement

Millions USD. Fiscal year is May - Apr.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jul '24 Apr '24 Apr '23 Apr '22 Apr '21 Apr '20
Revenue
0.020.020.010.010.030.06
Revenue Growth (YoY)
853.85%261.17%-64.17%-43.86%-60.11%-
Cost of Revenue
0.010.0100.010.010.05
Gross Profit
0.010.0100.010.010.02
Selling, General & Admin
3.533.443.651.710.871.8
Research & Development
3.542.882.4631.712.04
Operating Expenses
7.066.326.124.722.583.84
Operating Income
-7.05-6.31-6.11-4.71-2.57-3.82
Interest Expense
-0.34-0.35-0.24-0.37-0.13-0
Other Non Operating Income (Expenses)
0.10.0500-0-0
EBT Excluding Unusual Items
-7.29-6.61-6.35-5.08-2.7-3.82
Gain (Loss) on Sale of Assets
----0-0.01
Other Unusual Items
---0.250.250.02
Pretax Income
-7.29-6.61-6.35-4.83-2.45-3.81
Net Income
-7.29-6.61-6.35-4.83-2.45-3.81
Net Income to Common
-7.29-6.61-6.35-4.83-2.45-3.81
Shares Outstanding (Basic)
100000
Shares Outstanding (Diluted)
100000
Shares Change (YoY)
471.27%343.39%139.56%0.15%--
EPS (Basic)
-13.99-18.74-79.92-145.48-74.00-115.01
EPS (Diluted)
-13.99-18.74-79.92-145.48-74.00-115.01
Free Cash Flow
-6.75-6.13-5.79-3.65-2.45-3.85
Free Cash Flow Per Share
-12.95-17.40-72.85-109.86-74.02-116.22
Gross Margin
67.31%67.31%45.71%45.11%58.35%27.61%
Operating Margin
-37907.43%-33901.99%-118698.33%-32765.60%-10030.18%-5949.00%
Profit Margin
-39193.77%-35511.87%-123384.27%-33592.57%-9577.29%-5937.99%
Free Cash Flow Margin
-36285.46%-32981.94%-112463.79%-25367.54%-9580.56%-6000.78%
EBITDA
-7.02-6.28-6.09-4.68-2.53-3.77
D&A For EBITDA
0.030.030.030.030.030.05
EBIT
-7.05-6.31-6.11-4.71-2.57-3.82
Source: S&P Capital IQ. Standard template. Financial Sources.